{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T15:47:03Z","timestamp":1791906423926,"version":"4.3.4"},"reference-count":157,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:00:00Z","timestamp":1791849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:00:00Z","timestamp":1791849600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"DOI":"10.1007\/s00210-026-05948-9","type":"journal-article","created":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T02:24:59Z","timestamp":1791858299000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Combined rituximab and magnesium acetyl taurate therapy attenuates neurodegeneration via ERK\/c-JNK\/P38MAPK signaling modulation in methylmercury-induced amyotrophic lateral sclerosis-like neurotoxicity"],"prefix":"10.1007","author":[{"given":"Trina","family":"Saha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0034-835X","authenticated-orcid":false,"given":"Sidharth","family":"Mehan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,13]]},"reference":[{"issue":"6","key":"5948_CR1","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1007\/s11064-011-0450-1","volume":"36","author":"OM Abdel-Salam","year":"2011","unstructured":"Abdel-Salam OM, Khadrawy YA, Salem NA, Sleem AA (2011) Oxidative stress in a model of toxic demyelination in rat brain\u202f: the effect of piracetam and vinpocetine. Neurochem Res 36(6):1062\u20131072. https:\/\/doi.org\/10.1007\/s11064-011-0450-1","journal-title":"Neurochem Res"},{"issue":"1","key":"5948_CR2","doi-asserted-by":"publisher","first-page":"54","DOI":"10.59213\/TP.2025.248","volume":"6","author":"\u015e Akyol","year":"2025","unstructured":"Akyol \u015e, G\u00fczel T, \u00d6zcan A, Karaman S, Orhan MF, \u00dczel VH, \u00d6zay M, G\u00f6l DK, Y\u0131lmaz E, Demir B, Karaman K, B\u00fcy\u00fckavc\u0131 M, Karak\u00fckc\u00fc M, \u00dcnal E (2025) Rituximab in pediatric B-cell non-Hodgkin lymphoma: clinical outcomes and prognostic implications. Trends Pediatr 6(1):54\u201361. https:\/\/doi.org\/10.59213\/TP.2025.248","journal-title":"Trends Pediatr"},{"key":"5948_CR3","doi-asserted-by":"publisher","DOI":"10.2174\/1573407216999200723113054","author":"MM Alam","year":"2020","unstructured":"Alam MM, Minj E, Yadav RK, Mehan S (2020a) Neuroprotective potential of adenyl cyclase\/cAMP\/CREB and mitochondrial CoQ10 activator in amyotrophic lateral sclerosis rats. Curr Bioact Compd. https:\/\/doi.org\/10.2174\/1573407216999200723113054","journal-title":"Curr Bioact Compd"},{"key":"5948_CR4","doi-asserted-by":"publisher","unstructured":"Alam MM, Minj E, Yadav RK, Mehan S (2020b) Neuroprotective potential of adenyl cyclase\/cAMP\/CREB and mitochondrial CoQ10 activator in amyotrophic lateral sclerosis rats. 1\u201317. https:\/\/doi.org\/10.2174\/1573407216999200723113054","DOI":"10.2174\/1573407216999200723113054"},{"key":"5948_CR5","doi-asserted-by":"publisher","first-page":"151","DOI":"10.2147\/JIR.S243514","volume":"13","author":"MR Al-Ani","year":"2020","unstructured":"Al-Ani MR, Raju TK, Hachim MY, Hachim IY, Elemam NM, Guimei M, Bendardaf R, Maghazachi AA (2020) Rituximab prevents the development of experimental autoimmune encephalomyelitis (EAE): comparison with prophylactic, therapeutic or combinational regimens. J Inflamm Res 13:151\u2013164. https:\/\/doi.org\/10.2147\/JIR.S243514","journal-title":"J Inflamm Res"},{"issue":"11","key":"5948_CR6","doi-asserted-by":"publisher","first-page":"2866","DOI":"10.3390\/biomedicines10112866","volume":"10","author":"TH Albekairi","year":"2022","unstructured":"Albekairi TH, Kamra A, Bhardwaj S, Mehan S, Giri A, Suri M, Alshammari A, Alharbi M, Alasmari AF, Narula AS, Kalfin R (2022) Beta-boswellic acid reverses 3-nitropropionic acid-induced molecular, mitochondrial, and histopathological defects in experimental rat model of Huntington's disease. Biomedicines 10(11):2866. https:\/\/doi.org\/10.3390\/biomedicines10112866","journal-title":"Biomedicines"},{"issue":"6","key":"5948_CR7","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1002\/ana.24651","volume":"79","author":"P Alping","year":"2016","unstructured":"Alping P, Frisell T, Novakova L, Islam-Jakobsson P, Salzer J, Bj\u00f6rck A, Axelsson M, Malmestr\u00f6m C, Fink K, Lycke J, Svenningsson A, Piehl F (2016) Rituximab versus fingolimod after natalizumab in multiple sclerosis patients. Ann Neurol 79(6):950\u2013958. https:\/\/doi.org\/10.1002\/ana.24651","journal-title":"Ann Neurol"},{"key":"5948_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/21678421.2020.1753777.Keratinous","volume":"603","author":"AS Andrew","year":"2021","unstructured":"Andrew AS, Brien KMO, Jackson BP, Sandler DP, Kaye W, Wagner L, Stommel EJ, Horton KD, Mehta P, Weinberg CR (2021) HHS Public Access 603:1\u201316. https:\/\/doi.org\/10.1080\/21678421.2020.1753777.Keratinous","journal-title":"HHS Public Access"},{"issue":"6","key":"5948_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e16673","volume":"9","author":"MA Ansari","year":"2023","unstructured":"Ansari MA, Nadeem A, Attia SM, Bakheet SA, Alasmari AF, Alomar HA, Al-Mazroua HA, Alhamed AS, Shahid M, Alqinyah M, Assiri MA, Al-Hamamah MA, Alassmrry YA, Ahmad SF (2023) Rituximab exerts its anti-arthritic effects via inhibiting NF-\u03baB\/GM-CSF\/iNOS signaling in B cells in a mouse model of collagen-induced arthritis. Heliyon 9(6):e16673. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e16673","journal-title":"Heliyon"},{"issue":"2","key":"5948_CR10","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1007\/s12011-019-01663-0","volume":"192","author":"M Ates","year":"2019","unstructured":"Ates M, Kizildag S, Yuksel O, Hosgorler F, Yuce Z, Guvendi G, Kandis S, Karakilic A, Koc B, Uysal N (2019) Dose-dependent absorption profile of different magnesium compounds. Biol Trace Elem Res 192(2):244\u2013251. https:\/\/doi.org\/10.1007\/s12011-019-01663-0","journal-title":"Biol Trace Elem Res"},{"issue":"22","key":"5948_CR11","doi-asserted-by":"publisher","first-page":"3569","DOI":"10.3390\/cells11223569","volume":"11","author":"D Aydemir","year":"2022","unstructured":"Aydemir D, Surucu S, Basak AN, Ulusu NN (2022) Evaluation of the hematological and serum biochemistry parameters in the pre-symptomatic and symptomatic stages of ALS disease to support early diagnosis and prognosis. Cells 11(22):3569. https:\/\/doi.org\/10.3390\/cells11223569","journal-title":"Cells"},{"issue":"22","key":"5948_CR12","doi-asserted-by":"publisher","first-page":"E2504","DOI":"10.1212\/WNL.0000000000201260","volume":"99","author":"P Barreras","year":"2022","unstructured":"Barreras P, Vasileiou ES, Filippatou AG, Fitzgerald KC, Levy M, Pardo CA, Newsome SD, Mowry EM, Calabresi PA, Sotirchos ES (2022) Long-term effectiveness and safety of rituximab in neuromyelitis optica spectrum disorder and MOG antibody disease. Neurology 99(22):E2504\u2013E2516. https:\/\/doi.org\/10.1212\/WNL.0000000000201260","journal-title":"Neurology"},{"issue":"1","key":"5948_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-021-01499-6","volume":"11","author":"A Behzadi","year":"2021","unstructured":"Behzadi A, Pujol-Calder\u00f3n F, Tjust AE, Wuolikainen A, H\u00f6glund K, Forsberg K, Portelius E, Blennow K, Zetterberg H, Andersen PM (2021) Neurofilaments can differentiate ALS subgroups and ALS from common diagnostic mimics. Sci Rep 11(1):1\u201312. https:\/\/doi.org\/10.1038\/s41598-021-01499-6","journal-title":"Sci Rep"},{"issue":"April","key":"5948_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmolb.2022.823174","volume":"9","author":"BD Belviso","year":"2022","unstructured":"Belviso BD, Mangiatordi GF, Alberga D, Mangini V, Carrozzini B, Caliandro R (2022) Structural characterization of the full-length anti-CD20 antibody rituximab. Front Mol Biosci 9(April):1\u201318. https:\/\/doi.org\/10.3389\/fmolb.2022.823174","journal-title":"Front Mol Biosci"},{"issue":"July","key":"5948_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.npep.2022.102296","volume":"96","author":"S Bhalla","year":"2022","unstructured":"Bhalla S, Mehan S (2022) Neuropeptides 4-hydroxyisoleucine mediated IGF-1\/GLP-1 signalling activation prevents propionic acid-induced autism-like behavioural phenotypes and neurochemical defects in experimental rats. Neuropeptides 96(July):102296. https:\/\/doi.org\/10.1016\/j.npep.2022.102296","journal-title":"Neuropeptides"},{"issue":"2","key":"5948_CR16","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1007\/s12035-018-1132-7","volume":"56","author":"S Bhowmick","year":"2019","unstructured":"Bhowmick S, D\u2019Mello V, Abdul-Muneer PM (2019) Synergistic inhibition of ERK1\/2 and JNK, not p38, phosphorylation ameliorates neuronal damages after traumatic brain injury. Mol Neurobiol 56(2):1124\u20131136. https:\/\/doi.org\/10.1007\/s12035-018-1132-7","journal-title":"Mol Neurobiol"},{"issue":"August","key":"5948_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2023.578200","volume":"384","author":"S Chhabra","year":"2023","unstructured":"Chhabra S, Mehan S, Khan Z, Gupta GD, Narula AS (2023) Matrine mediated neuroprotective potential in experimental multiple sclerosis: evidence from CSF, blood markers, brain samples and in-silico investigations. J Neuroimmunol 384(August):578200. https:\/\/doi.org\/10.1016\/j.jneuroim.2023.578200","journal-title":"J Neuroimmunol"},{"issue":"February","key":"5948_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2025.177417","volume":"995","author":"D Choudhary","year":"2025","unstructured":"Choudhary D, Nasiruddin Khan MD, Khan Z, Mehan S, Gupta GD, Narula AS, Samant R (2025) Navigating the complexities of neuronal signaling and targets in neurological disorders: from pathology to therapeutics. Eur J Pharmacol 995(February):177417. https:\/\/doi.org\/10.1016\/j.ejphar.2025.177417","journal-title":"Eur J Pharmacol"},{"key":"5948_CR19","doi-asserted-by":"publisher","unstructured":"Choudhary D, Mehan S, Mukherjee R, Khan MN, Gupta GD, Samant R, Tongra M (2026) Multitarget therapeutic potential of sulforaphane in ethidium bromide-induced neurotoxicity in multiple sclerosis-like pathology: comparison with omaveloxolone and dimethyl fumarate on neuroprotection and systemic recovery. Sci Rep. https:\/\/doi.org\/10.1038\/s41598-026-61362-4","DOI":"10.1038\/s41598-026-61362-4"},{"issue":"12","key":"5948_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00018-023-05007-z","volume":"80","author":"F Crozet","year":"2023","unstructured":"Crozet F, Levayer R (2023) Emerging roles and mechanisms of ERK pathway mechanosensing. Cell Mol Life Sci 80(12):1\u201319. https:\/\/doi.org\/10.1007\/s00018-023-05007-z","journal-title":"Cell Mol Life Sci"},{"key":"5948_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2025.578598","volume":"403","author":"A Dhiman","year":"2025","unstructured":"Dhiman A, Choudhary D, Mehan S, Maurya PK, Sharma AK, Kumar A, Mukherjee R, Gupta S, Khan Z, Gupta GD, Narula AS (2025) Therapeutic potential of Baicalin against experimental obsessive compulsive disorder: evidence from CSF, blood plasma, and brain analysis. J Neuroimmunol 403:578598. https:\/\/doi.org\/10.1016\/j.jneuroim.2025.578598","journal-title":"J Neuroimmunol"},{"key":"5948_CR22","doi-asserted-by":"publisher","unstructured":"Ding Q, Hu W, Wang R, Yang Q, Zhu M, Li M, Cai J, Rose P, Mao J, Zhu YZ (2023) Signaling pathways in rheumatoid arthritis: implications for targeted therapy. Signal Transduct Target Ther\u00a08(1). https:\/\/doi.org\/10.1038\/s41392-023-01331-9","DOI":"10.1038\/s41392-023-01331-9"},{"issue":"7","key":"5948_CR23","doi-asserted-by":"publisher","first-page":"601","DOI":"10.2174\/1567205017666201007120112","volume":"17","author":"P Duggal","year":"2020","unstructured":"Duggal P, Jadaun KS, Siqqiqui EM, Mehan S (2020) Investigation of low dose cabazitaxel potential as microtubule stabilizer in experimental model of Alzheimer\u2019s disease: restoring neuronal cytoskeleton. Curr Alzheimer Res 17(7):601\u2013615. https:\/\/doi.org\/10.2174\/1567205017666201007120112","journal-title":"Curr Alzheimer Res"},{"key":"5948_CR24","doi-asserted-by":"publisher","unstructured":"El-Eraky El-Azab N, El-Mahalaway AM, Sabry D (2018) Effect of methyl mercury on the cerebellar cortex of rats and the possible neuroprotective role of mesenchymal stem cells conditioned medium. Histological and immunohistochemical study. J Gastrointest Cancer Stromal Tumors\u00a008(06). https:\/\/doi.org\/10.4172\/2572-4126.1000430","DOI":"10.4172\/2572-4126.1000430"},{"key":"5948_CR25","doi-asserted-by":"publisher","unstructured":"El-Ouakhoumi A, Joulal H, Yousfi J, Benjilali L, Zahlane M, Essaadouni L (2024) Refractory depressive disorder as the first manifestation of adolescent Sj\u00f6gren\u2019s syndrome, successfully treated with rituximab. Eur J Case Rep Intern Med\u00a011(7):2\u20133. https:\/\/doi.org\/10.12890\/2024_004621","DOI":"10.12890\/2024_004621"},{"issue":"4","key":"5948_CR26","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1684\/mrh.2021.0475","volume":"33","author":"M Fassin","year":"2020","unstructured":"Fassin M, Danhier P, Ris L (2020) Effect of oral administration of magnesium n-acetyltaurinate on synaptic plasticity in rodents. Magnes Res 33(4):106\u2013113. https:\/\/doi.org\/10.1684\/mrh.2021.0475","journal-title":"Magnes Res"},{"issue":"1","key":"5948_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-024-67165-9","volume":"14","author":"C Femiano","year":"2024","unstructured":"Femiano C, Bruno A, Gilio L, Buttari F, Dolcetti E, Galifi G, Azzolini F, Borrelli A, Furlan R, Finardi A, Musella A, Mandolesi G, Storto M, Centonze D, Stampanoni Bassi M (2024) Inflammatory signature in amyotrophic lateral sclerosis predicting disease progression. Sci Rep 14(1):1\u201311. https:\/\/doi.org\/10.1038\/s41598-024-67165-9","journal-title":"Sci Rep"},{"key":"5948_CR28","doi-asserted-by":"publisher","unstructured":"Flores K, Yadav S (2019)\u00a0The nuclear translocation of mitogen-activated protein kinases\u202f: molecular the nuclear translocation of mitogen-activated protein kinases\u202f: molecular mechanisms and use as novel therapeutic target. https:\/\/doi.org\/10.1159\/000494085","DOI":"10.1159\/000494085"},{"issue":"8","key":"5948_CR29","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1001\/jamaneurol.2013.234","volume":"70","author":"BR Foerster","year":"2013","unstructured":"Foerster BR, Pomper MG, Callaghan BC, Petrou M, Edden RAE, Mohamed MA, Welsh RC, Carlos RC, Barker PB, Feldman EL (2013) An imbalance between excitatory and inhibitory neurotransmitters in amyotrophic lateral sclerosis revealed by use of 3-t proton magnetic resonance spectroscopy. JAMA Neurol 70(8):1009\u20131016. https:\/\/doi.org\/10.1001\/jamaneurol.2013.234","journal-title":"JAMA Neurol"},{"key":"5948_CR30","doi-asserted-by":"publisher","unstructured":"Fondell (2014) Magnesium intake and risk of amyotrophic lateral sclerosis: results from five large cohort studies Elinor. Bone\u00a023(1):1\u20137. https:\/\/doi.org\/10.3109\/21678421.2013.803577.Magnesium","DOI":"10.3109\/21678421.2013.803577.Magnesium"},{"issue":"5","key":"5948_CR31","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1001\/jamaneurol.2016.5398","volume":"74","author":"A Gaiani","year":"2017","unstructured":"Gaiani A, Martinelli I, Bello L, Querin G, Puthenparampil M, Ruggero S, Toffanin E, Cagnin A, Briani C, Pegoraro E, Soraru G (2017) Diagnostic and prognostic biomarkers in amyotrophic lateral sclerosis: neurofilament light chain levels in definite subtypes of disease. JAMA Neurol 74(5):525\u2013532. https:\/\/doi.org\/10.1001\/jamaneurol.2016.5398","journal-title":"JAMA Neurol"},{"issue":"4","key":"5948_CR32","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1038\/s41380-024-02750-y","volume":"30","author":"M Gallwitz","year":"2025","unstructured":"Gallwitz M, Lindqvist I, Mulder J, Rasmusson AJ, Larsson A, Hus\u00e9n E, Borin J, van der Spek PJ, Sabbagh N, Widgren A, Bergquist J, Cervenka S, Burman J, Cunningham JL (2025) Three cases with chronic obsessive compulsive disorder report gains in wellbeing and function following rituximab treatment. Mol Psychiatry 30(4):1396\u20131406. https:\/\/doi.org\/10.1038\/s41380-024-02750-y","journal-title":"Mol Psychiatry"},{"issue":"9","key":"5948_CR33","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.3390\/ph16091286","volume":"16","author":"P Ganguly","year":"2023","unstructured":"Ganguly P, Macleod T, Wong C, Harland M, McGonagle D (2023) Revisiting p38 mitogen-activated protein kinases (MAPK) in inflammatory arthritis: a narrative of the emergence of MAPK-activated protein kinase inhibitors (MK2i). Pharmaceuticals (Basel) 16(9):1286. https:\/\/doi.org\/10.3390\/ph16091286","journal-title":"Pharmaceuticals (Basel)"},{"issue":"4","key":"5948_CR34","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1080\/00365513.2019.1591636","volume":"79","author":"X Gao","year":"2019","unstructured":"Gao X, Yin J, Wang X, Petersen F, Yu X (2019) A comprehensive comparison of hematological parameters among 39 common diseases. Scand J Clin Lab Invest 79(4):251\u2013259. https:\/\/doi.org\/10.1080\/00365513.2019.1591636","journal-title":"Scand J Clin Lab Invest"},{"issue":"12","key":"5948_CR35","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1289\/ehp.0900855","volume":"117","author":"RM Gardner","year":"2009","unstructured":"Gardner RM, Nyland JF, Evans SL, Wang SB, Doyle KM, Crainiceanu CM, Silbergeld EK (2009) Mercury induces an unopposed inflammatory response in human peripheral blood mononuclear cells in vitro. Environ Health Perspect 117(12):1932\u20131938. https:\/\/doi.org\/10.1289\/ehp.0900855","journal-title":"Environ Health Perspect"},{"key":"5948_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-0624-8","author":"KL Gibbs","year":"2018","unstructured":"Gibbs KL, Kalmar B, Rhymes ER, Fellows AD, Ahmed M, Whiting P, Davies CH, Greensmith L, Schiavo G (2018) Inhibiting p38 MAPK alpha rescues axonal retrograde transport defects in a mouse model of ALS. Cell Death Dis. https:\/\/doi.org\/10.1038\/s41419-018-0624-8","journal-title":"Cell Death Dis"},{"issue":"2","key":"5948_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ph14020092","volume":"14","author":"P Gklinos","year":"2021","unstructured":"Gklinos P, Papadopoulou M, Stanulovic V, Mitsikostas DD, Papadopoulos D (2021) Monoclonal antibodies as neurological therapeutics. Pharmaceuticals (Basel) 14(2):1\u201331. https:\/\/doi.org\/10.3390\/ph14020092","journal-title":"Pharmaceuticals (Basel)"},{"issue":"6","key":"5948_CR38","doi-asserted-by":"publisher","first-page":"826","DOI":"10.4161\/mabs.26008","volume":"5","author":"J Golay","year":"2013","unstructured":"Golay J, Semenzato G, Rambaldi A, Fo\u00e0 R, Gaidano G, Gamba E, Pane F, Pinto A, Specchia G, Zaja F, Regazzi M (2013) Lessons for the clinic from rituximab pharmacokinetics and pharmacodynamics. MAbs 5(6):826\u2013837. https:\/\/doi.org\/10.4161\/mabs.26008","journal-title":"MAbs"},{"key":"5948_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/antiox12101887","author":"E Grossini","year":"2023","unstructured":"Grossini E, De Marchi F, Venkatesan S, Mele A, Ferrante D, Mazzini L (2023) Effects of acetyl-L-carnitine on oxidative stress in amyotrophic lateral sclerosis patients: evaluation on plasma markers and members of the neurovascular unit. Antioxidants (Basel). https:\/\/doi.org\/10.3390\/antiox12101887","journal-title":"Antioxidants (Basel)"},{"key":"5948_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/J.JHAZMAT.2025.140079","volume":"499","author":"J Gu","year":"2025","unstructured":"Gu J, Hu J, Zhou D, Fan Y, He Y, Ji G, Jin X (2025) Gabapentin lactam induces neurodevelopmental deficits via calcium-mitochondria-ROS cascade. J Hazard Mater 499:140079. https:\/\/doi.org\/10.1016\/J.JHAZMAT.2025.140079","journal-title":"J Hazard Mater"},{"issue":"6","key":"5948_CR41","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1016\/j.kint.2021.08.025","volume":"100","author":"K Gulati","year":"2021","unstructured":"Gulati K, Edwards H, Prendecki M, Cairns TD, Condon M, Galliford J, Griffith M, Levy JB, Tam FWK, Tanna A, Pusey CD, McAdoo SP (2021) Combination treatment with rituximab, low-dose cyclophosphamide and plasma exchange for severe antineutrophil cytoplasmic antibody-associated vasculitis. Kidney Int 100(6):1316\u20131324. https:\/\/doi.org\/10.1016\/j.kint.2021.08.025","journal-title":"Kidney Int"},{"key":"5948_CR42","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.neuroscience.2025.01.021","volume":"569","author":"S Gupta","year":"2025","unstructured":"Gupta S, Gupta AK, Mehan S, Khan Z, Gupta GD, Narula AS (2025a) Disruptions in cellular communication: molecular interplay between glutamate\/NMDA signalling and MAPK pathways in neurological disorders. Neuroscience 569:331\u2013353. https:\/\/doi.org\/10.1016\/j.neuroscience.2025.01.021","journal-title":"Neuroscience"},{"key":"5948_CR43","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1201\/9781003686675-7","volume-title":"Vitamins & neurodegeneration","author":"S Gupta","year":"2025","unstructured":"Gupta S, Gupta AK, Mukherjee R, Mehan S (2025b) Vitamins D and K immunomodulatory and vascular protective roles in brain aging. In: Vitamins & neurodegeneration, pp 110\u2013140. https:\/\/doi.org\/10.1201\/9781003686675-7"},{"issue":"4","key":"5948_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11064-026-04820-9","volume":"51","author":"S Gupta","year":"2026","unstructured":"Gupta S, Mehan S, Gupta AK, Kumar A, Gupta GD, Narula AS, Samant R, Tongra M (2026) Combined puerarin and magnesium acetyl taurate intervention mitigates autism-like pathology through glutamatergic and MAPK pathway regulation. Neurochem Res 51(4):1\u201349. https:\/\/doi.org\/10.1007\/s11064-026-04820-9","journal-title":"Neurochem Res"},{"key":"5948_CR45","doi-asserted-by":"publisher","first-page":"17085","DOI":"10.1038\/nrdp.2017.85","volume":"3","author":"O Hardiman","year":"2017","unstructured":"Hardiman O, Al-Chalabi A, Chio A, Corr EM, Logroscino G, Robberecht W, Shaw PJ, Simmons Z, van den Berg LH (2017) Amyotrophic lateral sclerosis. Nature Rev Dis Primers 3:17085. https:\/\/doi.org\/10.1038\/nrdp.2017.85","journal-title":"Nature Rev Dis Primers"},{"key":"5948_CR46","doi-asserted-by":"publisher","unstructured":"Hayes MTG, Adam RJ, McCombe PA, Walsh M, Blum S (2024)\u00a0Long-term efficacy and safety of rituximab in the treatment of neuromyelitis Optica Spectrum disorder.\u00a0Mult Scler J Exp Transl Clin\u00a010(2). https:\/\/doi.org\/10.1177\/20552173241257876","DOI":"10.1177\/20552173241257876"},{"issue":"3","key":"5948_CR47","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.nbd.2006.05.009","volume":"23","author":"ELF Holzbaur","year":"2006","unstructured":"Holzbaur ELF, Howland DS, Weber N, Wallace K, She Y, Kwak S, Tchistiakova LA, Murphy E, Hinson J, Karim R, Tan XY, Kelley P, McGill KC, Williams G, Hobbs C, Doherty P, Zaleska MM, Pangalos MN, Walsh FS (2006) Myostatin inhibition slows muscle atrophy in rodent models of amyotrophic lateral sclerosis. Neurobiol Dis 23(3):697\u2013707. https:\/\/doi.org\/10.1016\/j.nbd.2006.05.009","journal-title":"Neurobiol Dis"},{"issue":"5","key":"5948_CR48","doi-asserted-by":"publisher","first-page":"723","DOI":"10.5137\/1019-5149.JTN.29272-20.1","volume":"30","author":"F Hosgorler","year":"2020","unstructured":"Hosgorler F, Koc B, Kizildag S, Canpolat S, Argon A, Karakilic A, Kandis S, Guvendi G, Ates M, Arda NM, Uysal N (2020) Magnesium acetyl taurate prevents tissue damage and deterioration of prosocial behavior related with vasopressin levels in traumatic brain injured rats. Turk Neurosurg 30(5):723\u2013733. https:\/\/doi.org\/10.5137\/1019-5149.JTN.29272-20.1","journal-title":"Turk Neurosurg"},{"issue":"6","key":"5948_CR49","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.1007\/s12035-020-01871-z","volume":"57","author":"H Hou","year":"2020","unstructured":"Hou H, Wang L, Fu T, Papasergi M, Yule DI, Xia H (2020) Magnesium acts as a second messenger in the regulation of NMDA receptor-mediated CREB signaling in neurons. Mol Neurobiol 57(6):2539\u20132550. https:\/\/doi.org\/10.1007\/s12035-020-01871-z","journal-title":"Mol Neurobiol"},{"issue":"1","key":"5948_CR50","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/s41598-017-09097-1","volume":"7","author":"Y Hu","year":"2017","unstructured":"Hu Y, Cao C, Qin XY, Yu Y, Yuan J, Zhao Y, Cheng Y (2017) Increased peripheral blood inflammatory cytokine levels in amyotrophic lateral sclerosis: a meta-analysis study. Sci Rep 7(1):12\u201315. https:\/\/doi.org\/10.1038\/s41598-017-09097-1","journal-title":"Sci Rep"},{"issue":"3","key":"5948_CR51","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.nbd.2011.05.013","volume":"43","author":"C Iaccarino","year":"2011","unstructured":"Iaccarino C, Mura ME, Esposito S, Carta F, Sanna G, Turrini F, Carr\u00ec MT, Crosio C (2011) Bcl2-A1 interacts with pro-caspase-3: implications for amyotrophic lateral sclerosis. Neurobiol Dis 43(3):642\u2013650. https:\/\/doi.org\/10.1016\/j.nbd.2011.05.013","journal-title":"Neurobiol Dis"},{"issue":"1","key":"5948_CR52","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12883-019-1299-1","volume":"19","author":"A Inoue-Shibui","year":"2019","unstructured":"Inoue-Shibui A, Kato M, Suzuki N, Kobayashi J, Takai Y, Izumi R, Kawauchi Y, Kuroda H, Warita H, Aoki M (2019) Interstitial pneumonia and other adverse events in riluzole-administered amyotrophic lateral sclerosis patients: a retrospective observational study. BMC Neurol 19(1):3\u20139. https:\/\/doi.org\/10.1186\/s12883-019-1299-1","journal-title":"BMC Neurol"},{"issue":"19","key":"5948_CR53","doi-asserted-by":"publisher","first-page":"7117","DOI":"10.1158\/0008-5472.CAN-03-3500","volume":"64","author":"AR Jazirehi","year":"2004","unstructured":"Jazirehi AR, Vega MI, Chatterjee D, Goodglick L, Bonavida B (2004) Inhibition of the Raf-MEK1\/2-ERK1\/2 signaling pathway, BCL-xL down-regulation, and chemosensitization of non-Hodgkin\u2019s lymphoma B cells by rituximab. Cancer Res 64(19):7117\u20137126. https:\/\/doi.org\/10.1158\/0008-5472.CAN-03-3500","journal-title":"Cancer Res"},{"issue":"5","key":"5948_CR54","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/nn.3357","volume":"16","author":"SH Kang","year":"2013","unstructured":"Kang SH, Li Y, Fukaya M, Lorenzini I, Cleveland DW, Ostrow LW, Rothstein JD, Bergles DE (2013) Degeneration and impaired regeneration of gray matter oligodendrocytes in amyotrophic lateral sclerosis. Nat Neurosci 16(5):571\u2013579. https:\/\/doi.org\/10.1038\/nn.3357","journal-title":"Nat Neurosci"},{"issue":"18","key":"5948_CR55","doi-asserted-by":"publisher","first-page":"2771","DOI":"10.3390\/cells11182771","volume":"11","author":"T Kapoor","year":"2022","unstructured":"Kapoor T, Mehan S, Suri M, Sharma N, Kumar N, Narula AS, Alshammari A, Alasmari AF, Alharbi M, Assiri MA, Kalfin R (2022) Forskolin, an Adenylcyclase\/cAMP\/CREB signaling activator restoring myelin-associated oligodendrocyte destruction in experimental ethidium bromide model of multiple sclerosis. Cells 11(18):2771. https:\/\/doi.org\/10.3390\/cells11182771","journal-title":"Cells"},{"issue":"4","key":"5948_CR56","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.3906\/sag-1911-13","volume":"50","author":"S Karak\u00f6se","year":"2020","unstructured":"Karak\u00f6se S, Bal AZ, Eser EP, Duranay M (2020) The effect of rituximab on encapsulated peritoneal sclerosis in an experimental rat model. Turk J Med Sci 50(4):1123\u20131130. https:\/\/doi.org\/10.3906\/sag-1911-13","journal-title":"Turk J Med Sci"},{"issue":"July","key":"5948_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2025.157448","volume":"148","author":"Z Khan","year":"2025","unstructured":"Khan Z, Mehan S, Gupta GD (2025) Therapeutic efficacy of 4-hydroxyisoleucine in experimental rat model of demyelination: neuroprotection through IGF-1 and GLP-1 level restoration. Phytomedicine 148(July):157448. https:\/\/doi.org\/10.1016\/j.phymed.2025.157448","journal-title":"Phytomedicine"},{"key":"5948_CR58","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2026.1792674","author":"N Khan","year":"2026","unstructured":"Khan N, Mehan S, Choudhary D (2026) Enhanced therapeutic potential of paeoniflorin and vitamin B12 in intracerebropeduncle ethidium bromide-induced multiple sclerosis-like pathology. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2026.1792674","journal-title":"Front Pharmacol"},{"issue":"3","key":"5948_CR59","doi-asserted-by":"publisher","first-page":"889","DOI":"10.3390\/molecules27030889","volume":"27","author":"R Khera","year":"2022","unstructured":"Khera R, Mehan S, Bhalla S, Kumar S, Alshammari A, Alharbi M, Sadhu SS (2022) Guggulsterone mediated JAK\/STAT and PPAR-gamma modulation prevents neurobehavioral and neurochemical abnormalities in propionic acid-induced experimental model of autism. Molecules (Basel) 27(3):889. https:\/\/doi.org\/10.3390\/molecules27030889","journal-title":"Molecules (Basel)"},{"key":"5948_CR60","doi-asserted-by":"publisher","DOI":"10.1038\/s43856-024-00573-0","author":"P K\u00f6rtv\u00e9lyessy","year":"2024","unstructured":"K\u00f6rtv\u00e9lyessy P, Schumann P, Valkadinov I, Weyen U, Hesebeck-brinckmann J, Weishaupt K, Endres M, Andersen PM, Regensburger M, Dreger M, Koch JC, Conrad J, Meyer T (2024) Tofersen decreases neuro filament levels supporting the pathogenesis of the SOD1 p. D91A variant in amyotrophic lateral sclerosis patients. Commun Med. https:\/\/doi.org\/10.1038\/s43856-024-00573-0","journal-title":"Commun Med"},{"issue":"5","key":"5948_CR61","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1007\/s11011-021-00691-x","volume":"36","author":"N Kumar","year":"2021","unstructured":"Kumar N, Sharma N, Khera R, Gupta R, Mehan S (2021) Guggulsterone ameliorates ethidium bromide-induced experimental model of multiple sclerosis via restoration of behavioral, molecular, neurochemical and morphological alterations in rat brain. Metab Brain Dis 36(5):911\u2013925. https:\/\/doi.org\/10.1007\/s11011-021-00691-x","journal-title":"Metab Brain Dis"},{"issue":"39","key":"5948_CR62","doi-asserted-by":"publisher","first-page":"3074","DOI":"10.2174\/0113816128321466240816075041","volume":"30","author":"A Kumar","year":"2024","unstructured":"Kumar A, Mehan S, Tiwari A, Khan Z, Gupta GD, Narula AS, Samant R (2024a) Magnesium (Mg2+): essential mineral for neuronal health: from cellular biochemistry to cognitive health and behavior regulation. Curr Pharm Des 30(39):3074\u20133107. https:\/\/doi.org\/10.2174\/0113816128321466240816075041","journal-title":"Curr Pharm Des"},{"key":"5948_CR63","doi-asserted-by":"publisher","unstructured":"Kumar S, Mehan S, Khan Z, Das Gupta G, Narula AS (2024b) Guggulsterone selectively modulates STAT-3, mTOR, and PPAR-gamma signaling in a methylmercury-exposed experimental neurotoxicity: evidence from CSF, blood plasma, and brain samples. Mol Neurobiol 61(8). Springer US. https:\/\/doi.org\/10.1007\/s12035-023-03902-x","DOI":"10.1007\/s12035-023-03902-x"},{"key":"5948_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2024.149251","volume":"1846","author":"M Kumar","year":"2025","unstructured":"Kumar M, Mehan S, Kumar A, Sharma T, Khan Z, Tiwari A, Das Gupta G, Narula AS (2025) Therapeutic efficacy of Genistein in activation of neuronal AC\/cAMP\/CREB\/PKA and mitochondrial ETC-complex pathways in experimental model of autism: evidence from CSF, blood plasma and brain analysis. Brain Res 1846:149251. https:\/\/doi.org\/10.1016\/j.brainres.2024.149251","journal-title":"Brain Res"},{"issue":"1\u20132","key":"5948_CR65","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.jneuroim.2005.11.015","volume":"172","author":"OI Kuzmenok","year":"2006","unstructured":"Kuzmenok OI, Sanberg PR, Desjarlais TG, Bennett SP, Garbuzova-Davis SN (2006) Lymphopenia and spontaneous autorosette formation in SOD1 mouse model of ALS. J Neuroimmunol 172(1\u20132):132\u2013136. https:\/\/doi.org\/10.1016\/j.jneuroim.2005.11.015","journal-title":"J Neuroimmunol"},{"issue":"1","key":"5948_CR66","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s12640-016-9658-9","volume":"31","author":"L Lambuk","year":"2017","unstructured":"Lambuk L, Jafri AJA, Arfuzir NNN, Iezhitsa I, Agarwal R, Rozali KNB, Agarwal P, Bakar NS, Kutty MK, Yusof APM, Krasilnikova A, Spasov A, Ozerov A, Ismail NM (2017) Neuroprotective effect of magnesium acetyltaurate against NMDA-induced excitotoxicity in rat retina. Neurotox Res 31(1):31\u201345. https:\/\/doi.org\/10.1007\/s12640-016-9658-9","journal-title":"Neurotox Res"},{"issue":"6","key":"5948_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/biomedicines10061307","volume":"10","author":"D Lanznaster","year":"2022","unstructured":"Lanznaster D, Bruno C, Bourgeais J, Emond P, Zemmoura I, Lef\u00e8vre A, Reynier P, Eymieux S, Blanchard E, Vourc\u2019h P, Andres CR, Bakkouche SE, Herault O, Favard L, Corcia P, Blasco H (2022) Metabolic profile and pathological alterations in the muscle of patients with early-stage amyotrophic lateral sclerosis. Biomedicines 10(6):1\u201320. https:\/\/doi.org\/10.3390\/biomedicines10061307","journal-title":"Biomedicines"},{"issue":"3","key":"5948_CR68","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.3390\/ijms21031102","volume":"21","author":"S Lee","year":"2020","unstructured":"Lee S, Rauch J, Kolch W (2020) Targeting MAPK signaling in cancer: mechanisms of drug resistance and sensitivity. Int J Mol Sci 21(3):1102. https:\/\/doi.org\/10.3390\/ijms21031102","journal-title":"Int J Mol Sci"},{"issue":"7","key":"5948_CR69","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1177\/0271678X18756499","volume":"39","author":"H Lei","year":"2019","unstructured":"Lei H, Dirren E, Poitry-Yamate C, Schneider BL, Gruetter R, Aebischer P (2019) Evolution of the neurochemical profiles in the G93A-SOD1 mouse model of amyotrophic lateral sclerosis. J Cereb Blood Flow Metab 39(7):1283\u20131298. https:\/\/doi.org\/10.1177\/0271678X18756499","journal-title":"J Cereb Blood Flow Metab"},{"issue":"14","key":"5948_CR70","doi-asserted-by":"publisher","first-page":"4672","DOI":"10.1158\/1078-0432.CCR-11-0479","volume":"17","author":"TS Lewis","year":"2011","unstructured":"Lewis TS, McCormick RS, Emmerton K, Lau JT, Yu SF, McEarchern JA, Grewal IS, Law CL (2011) Distinct apoptotic signaling characteristics of the anti-CD40 monoclonal antibody dacetuzumab and rituximab produce enhanced antitumor activity in non-Hodgkin lymphoma. Clin Cancer Res 17(14):4672\u20134681. https:\/\/doi.org\/10.1158\/1078-0432.CCR-11-0479","journal-title":"Clin Cancer Res"},{"key":"5948_CR71","doi-asserted-by":"publisher","DOI":"10.4238\/2013.August.16.1","author":"L Li","year":"2013","unstructured":"Li L, Zhao YW, Zeng JS, Fan F, Wang X, Zhou Y, Zhu Z (2013) Rituximab regulates the expression of the raf kinase inhibitor protein via NF-\u03baB in renal tissue of rats with diabetic nephropathy. Genet Mol Res. https:\/\/doi.org\/10.4238\/2013.August.16.1","journal-title":"Genet Mol Res"},{"issue":"1","key":"5948_CR72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13041-014-0065-y","volume":"7","author":"W Li","year":"2014","unstructured":"Li W, Yu J, Liu Y, Huang X, Abumaria N, Zhu Y, Huang X, Xiong W, Ren C, Liu XG, Chui D, Liu G (2014) Elevation of brain magnesium prevents synaptic loss and reverses cognitive deficits in Alzheimer\u2019s disease mouse model. Mol Brain 7(1):1\u201320. https:\/\/doi.org\/10.1186\/s13041-014-0065-y","journal-title":"Mol Brain"},{"key":"5948_CR73","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-022-16229-9","volume":"0123456789","author":"JY Li","year":"2022","unstructured":"Li JY, Sun XH, Cai ZY, Shen D, Yang XZ (2022) Correlation of weight and body composition with disease progression rate in patients with amyotrophic lateral sclerosis. Sci Rep 0123456789:1\u20139. https:\/\/doi.org\/10.1038\/s41598-022-16229-9","journal-title":"Sci Rep"},{"issue":"5\u20136","key":"5948_CR74","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1080\/21678421.2022.2122845","volume":"24","author":"X Li","year":"2023","unstructured":"Li X, Armon C, Barkhaus P, Barnes B, Benatar M, Bertorini T, Bromberg M, Carter GT, Crayle J, Cudkowicz M, Dimachkie M, Feldman EL, Glass J, Goslinga J, Heiman-Patterson T, Jhooty S, Lichtenstein R, Lund I, Mcdermott C, Pattee G, Pierce K, Ratner D, Salmon K, Wicks P, Bedlack R (2023) ALSUntangled #67: rituximab. Amyotroph Lateral Scler Frontotemporal Degener 24(5\u20136):544\u2013547. https:\/\/doi.org\/10.1080\/21678421.2022.2122845","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"20","key":"5948_CR75","doi-asserted-by":"publisher","first-page":"578","DOI":"10.21037\/atm.2019.09.70","volume":"7","author":"M Liu","year":"2019","unstructured":"Liu M, Yang H, Mao Y (2019a) Magnesium and liver disease. Ann Transl Med 7(20):578\u2013578. https:\/\/doi.org\/10.21037\/atm.2019.09.70","journal-title":"Ann Transl Med"},{"issue":"1","key":"5948_CR76","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1080\/10715762.2018.1546852","volume":"53","author":"W Liu","year":"2019","unstructured":"Liu W, Yang T, Xu Z, Xu B, Deng Y (2019b) Methyl-mercury induces apoptosis through ROS-mediated endoplasmic reticulum stress and mitochondrial apoptosis pathways activation in rat cortical neurons. Free Radic Res 53(1):26\u201344. https:\/\/doi.org\/10.1080\/10715762.2018.1546852","journal-title":"Free Radic Res"},{"key":"5948_CR77","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2025.2586335","author":"B Liu","year":"2025","unstructured":"Liu B, Zhang W, Chen Y, Han A, Chen D (2025) Pharmacovigilance analysis of FcRn antagonists in the treatment of myasthenia gravis: a disproportionality analysis based on the FAERS database. Hum Vaccin Immunother. https:\/\/doi.org\/10.1080\/21645515.2025.2586335","journal-title":"Hum Vaccin Immunother"},{"issue":"6","key":"5948_CR78","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1152\/ajpcell.00114.2011","volume":"301","author":"S Lokireddy","year":"2011","unstructured":"Lokireddy S, Mouly V, Butler-Browne G, Gluckman PD, Sharma M, Kambadur R, McFarlane C (2011) Myostatin promotes the wasting of human myoblast cultures through promoting ubiquitin-proteasome pathway-mediated loss of sarcomeric proteins. Am J Physiol Cell Physiol 301(6):1316\u20131324. https:\/\/doi.org\/10.1152\/ajpcell.00114.2011","journal-title":"Am J Physiol Cell Physiol"},{"issue":"1","key":"5948_CR79","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1179\/174313209X385734","volume":"32","author":"L Lombardi","year":"2010","unstructured":"Lombardi L, Ascenzo CD, Baggio L, Ermani M, Palmieri A, Soraru G, Pegoraro E, Angelini C (2010) Quality of Life and Motor Impairment in ALS\u202f: Italian Validation of ALS. Neurol Res 32(1):32\u201340. https:\/\/doi.org\/10.1179\/174313209X385734","journal-title":"Neurol Res"},{"issue":"7\u20138","key":"5948_CR80","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1080\/21678421.2018.1497065","volume":"19","author":"E Longinetti","year":"2018","unstructured":"Longinetti E, Regod\u00f3n Wallin A, Samuelsson K, Press R, Zachau A, Ronnevi LO, Kierkegaard M, Andersen PM, Hillert J, Fang F, Ingre C (2018) The Swedish motor neuron disease quality registry. Amyotroph Lateral Scler Frontotemporal Degener 19(7\u20138):528\u2013537. https:\/\/doi.org\/10.1080\/21678421.2018.1497065","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"5948_CR81","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuroscience.2020.01.026","volume":"430","author":"J Lu","year":"2020","unstructured":"Lu J, Zhou H, Meng D, Zhang J, Pan K, Wan B, Miao Z (2020) Tanshinone IIA improves depression-like behavior in mice by activating the ERK-CREB-BDNF signaling pathway. Neuroscience 430:1\u201311. https:\/\/doi.org\/10.1016\/j.neuroscience.2020.01.026","journal-title":"Neuroscience"},{"issue":"193","key":"5948_CR82","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.108804","volume":"114","author":"XL Ma","year":"2019","unstructured":"Ma XL, Lin QY, Wang L, Xie X, Zhang YL, Li HH (2019) Rituximab prevents and reverses cardiac remodeling by depressing B cell function in mice. Biomed Pharmacother 114(193):108804. https:\/\/doi.org\/10.1016\/j.biopha.2019.108804","journal-title":"Biomed Pharmacother"},{"key":"5948_CR83","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2024.149767","author":"W Ma","year":"2024","unstructured":"Ma W, Wang S, Fan Q, Wang Y, Chu C, Liu D, Guo Z, Tang J, Wen J (2024) Mild hypothermia reduces lipopolysaccharide-induced microglial activation via down-regulation of Tent5c. Biochem Biophys Res Commun. https:\/\/doi.org\/10.1016\/j.bbrc.2024.149767","journal-title":"Biochem Biophys Res Commun"},{"key":"5948_CR84","doi-asserted-by":"publisher","unstructured":"Magr\u00ec A, Lucia C, Lipari R, Risiglione P, Zimbone S, Guarino F, Caccamo A (2023)\u00a0ERK1 \/ 2-dependent TSPO overactivation associates with the loss of mitophagy and mitochondrial respiration in ALS.\u00a01\u201310. https:\/\/doi.org\/10.1038\/s41419-023-05643-0","DOI":"10.1038\/s41419-023-05643-0"},{"issue":"8","key":"5948_CR85","doi-asserted-by":"publisher","first-page":"4031","DOI":"10.1007\/s00415-023-11753-8","volume":"270","author":"PM Maier","year":"2023","unstructured":"Maier PM, Iggena D, Meyer T, Finke C, Ploner CJ (2023) Memory - guided navigation in amyotrophic lateral sclerosis. J Neurol 270(8):4031\u20134040. https:\/\/doi.org\/10.1007\/s00415-023-11753-8","journal-title":"J Neurol"},{"key":"5948_CR86","doi-asserted-by":"publisher","unstructured":"Maltsev D (2025) Efficacy of rituximab in autism spectrum disorders associated with genetic deficiency of the folate cycle with signs of antineuronal autoimmunity. Immunodiagnostics and Immunotherapy of Neuropsychiatric Disorders in Children.\u00a0pp 158\u2013169. https:\/\/doi.org\/10.15587\/978-617-8360-21-4.ch12","DOI":"10.15587\/978-617-8360-21-4.ch12"},{"issue":"10","key":"5948_CR87","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1111\/ene.14393","volume":"27","author":"P Masrori","year":"2020","unstructured":"Masrori P, Van Damme P (2020) Amyotrophic lateral sclerosis: a clinical review. Eur J Neurol 27(10):1918\u20131929. https:\/\/doi.org\/10.1111\/ene.14393","journal-title":"Eur J Neurol"},{"key":"5948_CR88","doi-asserted-by":"publisher","DOI":"10.1007\/s11055-026-01981-6","author":"PK Maurya","year":"2026","unstructured":"Maurya PK, Mehan S, Das Gupta G (2026) Multitarget therapeutic potential of icariin and tanshinone IIA via activation of SIRT-1\/Nrf2\/HO-1 signalling in intracerebral peduncular region ethidium bromide-induced multiple sclerosis-like pathology. Neurosci Behav Physiol. https:\/\/doi.org\/10.1007\/s11055-026-01981-6","journal-title":"Neurosci Behav Physiol"},{"issue":"3","key":"5948_CR89","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1002\/jmri.24582","volume":"41","author":"MD Meadowcroft","year":"2015","unstructured":"Meadowcroft MD, Mutic NJ, Bigler DC, Wang JL, Simmons Z, Connor JR, Yang QX (2015) Histological-MRI correlation in the primary motor cortex of patients with amyotrophic lateral sclerosis. J Magn Reson Imaging 41(3):665\u2013675. https:\/\/doi.org\/10.1002\/jmri.24582","journal-title":"J Magn Reson Imaging"},{"issue":"6","key":"5948_CR90","doi-asserted-by":"publisher","first-page":"783","DOI":"10.5137\/1019-5149.JTN.8051-13.0","volume":"23","author":"G Menekse","year":"2013","unstructured":"Menekse G, Daglioglu E, Nacar OA, Polat E, Ozdol C, Dalgic A, Take G, Okten AI, Belen AD (2013) The neuroprotective effects of rituximab in rat spinal cord injury model: an immunohistochemical study. Turk Neurosurg 23(6):783\u2013790. https:\/\/doi.org\/10.5137\/1019-5149.JTN.8051-13.0","journal-title":"Turk Neurosurg"},{"key":"5948_CR91","doi-asserted-by":"publisher","DOI":"10.1007\/s11064-021-03366-2","author":"E Minj","year":"2021","unstructured":"Minj E, Upadhayay S, Mehan S (2021a) Nrf2 \/ HO\u20111 signaling activator acetyl\u201111\u2011keto\u2011beta boswellic acid (AKBA)\u2011mediated neuroprotection in methyl mercury\u2011induced experimental model of ALS. Neurochem Res. https:\/\/doi.org\/10.1007\/s11064-021-03366-2","journal-title":"Neurochem Res"},{"issue":"8","key":"5948_CR92","doi-asserted-by":"publisher","first-page":"630","DOI":"10.2174\/1566524021666210111104920","volume":"21","author":"E Minj","year":"2021","unstructured":"Minj E, Yadav RK, Mehan S (2021b) Targeting abnormal Nrf2\/HO-1 signaling in amyotrophic lateral sclerosis: current insights on drug targets and influences on neurological disorders. Curr Mol Med 21(8):630\u2013644. https:\/\/doi.org\/10.2174\/1566524021666210111104920","journal-title":"Curr Mol Med"},{"issue":"3","key":"5948_CR93","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1128\/MMBR.00043-14.Address","volume":"80","author":"M Misheva","year":"2016","unstructured":"Misheva M, Bogoyevitch MA (2016) JNK Signaling\u202f: Regulation and Functions Based on Complex Protein- Protein Partnerships 80(3):793\u2013835. https:\/\/doi.org\/10.1128\/MMBR.00043-14.Address","journal-title":"JNK Signaling : Regulation and Functions Based on Complex Protein- Protein Partnerships"},{"issue":"1","key":"5948_CR94","doi-asserted-by":"publisher","first-page":"30781","DOI":"10.1038\/s41598-024-80851-y","volume":"14","author":"E Mitsi","year":"2024","unstructured":"Mitsi E, Votsi C, Koutsou P, Georghiou A, Christodoulou CC, Kleopa K, Zamba-Papanicolaou E, Christodoulou K, Nicolaou P (2024) Genetic epidemiology of amyotrophic lateral sclerosis in Cyprus: a population-based study. Sci Rep 14(1):30781. https:\/\/doi.org\/10.1038\/s41598-024-80851-y","journal-title":"Sci Rep"},{"issue":"1","key":"5948_CR95","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-025-94760-1","volume":"15","author":"RH Mohyeldin","year":"2025","unstructured":"Mohyeldin RH, Sharata EE, Fawzy MA, Attya ME, Welson NN, Rofaeil RR (2025) Memantine abrogates testicular dysfunction induced by risperidone in rats with a potential role of ERK1\/2-Nrf2-caspase-3 signaling pathway. Sci Rep 15(1):1\u201313. https:\/\/doi.org\/10.1038\/s41598-025-94760-1","journal-title":"Sci Rep"},{"key":"5948_CR96","doi-asserted-by":"publisher","unstructured":"Moisello C, Bove M, Huber R, Abbruzzese G, Battaglia F, Ghilardi MF (2008)\u00a0Short-term limb immobilization affects motor performance.\u00a037\u201341. https:\/\/doi.org\/10.3200\/JMBR.40.2.165-176","DOI":"10.3200\/JMBR.40.2.165-176"},{"key":"5948_CR97","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-025-04725-8","author":"R Mukherjee","year":"2025","unstructured":"Mukherjee R, Rana R, Mehan S, Khan Z, Das Gupta G, Narula AS, Samant R (2025) Investigating the interplay between the Nrf2\/Keap1\/HO-1\/SIRT-1 pathway and the p75NTR\/PI3K\/Akt\/MAPK cascade in neurological disorders: mechanistic insights and therapeutic innovations. Mol Neurobiol. https:\/\/doi.org\/10.1007\/s12035-025-04725-8","journal-title":"Mol Neurobiol"},{"key":"5948_CR98","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-026-05683-5","author":"R Mukherjee","year":"2026","unstructured":"Mukherjee R, Mehan S, Choudhary D, Rana R, Das Gupta G, Samant R, Tongra M (2026a) Sulforaphane-mediated multitarget therapeutic effects in methylmercury-induced ALS-like pathology: comparative analysis and multifaceted approach to neuroprotection and systemic recovery. Mol Neurobiol. https:\/\/doi.org\/10.1007\/s12035-026-05683-5","journal-title":"Mol Neurobiol"},{"key":"5948_CR99","volume-title":"Sulforaphane - mediated multitarget therapeutic effects in methylmercury - induced ALS - like pathology : comparative analysis and multifaceted approach to neuroprotection and systemic recovery","author":"R Mukherjee","year":"2026","unstructured":"Mukherjee R, Mehan S, Choudhary D, Rana R, Gupta GD (2026b) Sulforaphane - mediated multitarget therapeutic effects in methylmercury - induced ALS - like pathology\u202f: comparative analysis and multifaceted approach to neuroprotection and systemic recovery. Springer, US"},{"issue":"8","key":"5948_CR100","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1158\/1078-0432.CCR-10-2923","volume":"17","author":"LL Muldoon","year":"2011","unstructured":"Muldoon LL, Lewin SJ, D\u00f3sa E, Kraemer DF, Pagel MA, Doolittle ND, Neuwelt EA (2011) Imaging and therapy with rituximab anti-CD20 immunotherapy in an animal model of central nervous system lymphoma. Clin Cancer Res 17(8):2207\u20132215. https:\/\/doi.org\/10.1158\/1078-0432.CCR-10-2923","journal-title":"Clin Cancer Res"},{"issue":"4","key":"5948_CR101","doi-asserted-by":"publisher","first-page":"963","DOI":"10.32604\/BIOCELL.2021.015297","volume":"45","author":"H Niu","year":"2021","unstructured":"Niu H, Chen X, Fu X, Zhang J, Li G, Wang Y, Song J, Ma X, Hu C, Xu X, Zhang F, Zeng L (2021) SOD1G93A induces a unique PSAP-dependent mitochondrial apoptosis pathway via Bax\u2013Bak interaction. Biocell 45(4):963\u2013970. https:\/\/doi.org\/10.32604\/BIOCELL.2021.015297","journal-title":"Biocell"},{"issue":"6","key":"5948_CR102","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms22063101","volume":"22","author":"JP Novo","year":"2021","unstructured":"Novo JP, Martins B, Raposo RS, Pereira FC, Ori\u00e1 RB, Malva JO, Fontes-Ribeiro C (2021) Cellular and molecular mechanisms mediating methylmercury neurotoxicity and neuroinflammation. Int J Mol Sci 22(6):1\u201325. https:\/\/doi.org\/10.3390\/ijms22063101","journal-title":"Int J Mol Sci"},{"issue":"2","key":"5948_CR103","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1093\/brain\/aws339","volume":"136","author":"T Philips","year":"2013","unstructured":"Philips T, Bento-Abreu A, Nonneman A, Haeck W, Staats K, Geelen V, Hersmus N, K\u00fcsters B, Van Den Bosch L, Van Damme P, Richardson WD, Robberecht W (2013) Oligodendrocyte dysfunction in the pathogenesis of amyotrophic lateral sclerosis. Brain 136(2):471\u2013482. https:\/\/doi.org\/10.1093\/brain\/aws339","journal-title":"Brain"},{"issue":"6","key":"5948_CR104","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1007\/s11064-023-04082-9","volume":"49","author":"A Prajapati","year":"2024","unstructured":"Prajapati A, Mehan S, Khan Z, Chhabra S, Das Gupta G (2024) Purmorphamine, a Smo-Shh\/Gli activator, promotes sonic hedgehog-mediated neurogenesis and restores behavioural and neurochemical deficits in experimental model of multiple sclerosis. Neurochem Res 49(6):1556\u20131576. https:\/\/doi.org\/10.1007\/s11064-023-04082-9","journal-title":"Neurochem Res"},{"issue":"March","key":"5948_CR105","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.ibror.2020.03.001","volume":"8","author":"K Rajdev","year":"2020","unstructured":"Rajdev K, Siddiqui EM, Jadaun KS, Mehan S (2020) Neuroprotective potential of solanesol in a combined model of intracerebral and intraventricular hemorrhage in rats. IBRO Rep 8(March):101\u2013114. https:\/\/doi.org\/10.1016\/j.ibror.2020.03.001","journal-title":"IBRO Rep"},{"issue":"March","key":"5948_CR106","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2025.115545","volume":"485","author":"R Rana","year":"2025","unstructured":"Rana R, Mukherjee R, Mehan S, Khan Z, Das Gupta G, Narula AS (2025) Molecular mechanisms of neuroprotection: the interplay of Klotho, SIRT-1, Nrf2, and HO-1 in neurological health. Behav Brain Res 485(March):115545. https:\/\/doi.org\/10.1016\/j.bbr.2025.115545","journal-title":"Behav Brain Res"},{"key":"5948_CR107","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-026-05871-3","volume-title":"Caffeic acid phenethyl ester enhanced the Klotho \/ SIRT1 \/ Nrf2 \/ HO - 1 axis to protect against methylmercury - induced ALS - like neurodegeneration","author":"R Rana","year":"2026","unstructured":"Rana R, Mehan S, Mukherjee R, Khan N, Gupta GD (2026) Caffeic acid phenethyl ester enhanced the Klotho \/ SIRT1 \/ Nrf2 \/ HO - 1 axis to protect against methylmercury - induced ALS - like neurodegeneration. Springer, US"},{"issue":"10","key":"5948_CR108","doi-asserted-by":"publisher","first-page":"3673","DOI":"10.1172\/JCI42986","volume":"120","author":"NA Reyes","year":"2010","unstructured":"Reyes NA, Fisher JK, Austgen K, VandenBerg S, Huang EJ, Oakes SA (2010) Blocking the mitochondrial apoptotic pathway preserves motor neuron viability and function in a mouse model of amyotrophic lateral sclerosis. J Clin Invest 120(10):3673\u20133679. https:\/\/doi.org\/10.1172\/JCI42986","journal-title":"J Clin Invest"},{"key":"5948_CR109","doi-asserted-by":"publisher","DOI":"10.1016\/j.steroids.2020.108586","volume":"156","author":"S Saad El-Din","year":"2020","unstructured":"Saad El-Din S, Rashed L, Medhat E, Emad Aboulhoda B, Desoky Badawy A, Mohammed ShamsEldeen A, Abdelgwad M (2020) Active form of vitamin D analogue mitigates neurodegenerative changes in Alzheimer\u2019s disease in rats by targeting Keap1\/Nrf2 and MAPK-38p\/ERK signaling pathways. Steroids 156:108586. https:\/\/doi.org\/10.1016\/j.steroids.2020.108586","journal-title":"Steroids"},{"issue":"0","key":"5948_CR110","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/08923973.2026.2671714","volume":"0","author":"T Saha","year":"2026","unstructured":"Saha T, Vats T, Mehan S (2026) Rituximab beyond oncology: targeting B-cell-mediated immunomodulatory therapy in neurodegenerative and neuropsychiatric disorders. Immunopharmacol Immunotoxicol 0(0):1\u201336. https:\/\/doi.org\/10.1080\/08923973.2026.2671714","journal-title":"Immunopharmacol Immunotoxicol"},{"issue":"8","key":"5948_CR111","doi-asserted-by":"publisher","first-page":"969","DOI":"10.3390\/biomedicines9080969","volume":"9","author":"TG Sahana","year":"2021","unstructured":"Sahana TG, Zhang K (2021) Mitogen-activated protein kinase pathway in amyotrophic lateral sclerosis. Biomedicines 9(8):969. https:\/\/doi.org\/10.3390\/biomedicines9080969","journal-title":"Biomedicines"},{"issue":"7\u20138","key":"5948_CR112","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejcb.2021.151179","volume":"100","author":"R Sahu","year":"2021","unstructured":"Sahu R, Upadhayay S, Mehan S (2021) Inhibition of extracellular regulated kinase (ERK)-1\/2 signaling pathway in the prevention of ALS: target inhibitors and influences on neurological dysfunctions. Eur J Cell Biol 100(7\u20138):151179. https:\/\/doi.org\/10.1016\/j.ejcb.2021.151179","journal-title":"Eur J Cell Biol"},{"issue":"April","key":"5948_CR113","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/j.toxrep.2022.04.023","volume":"9","author":"R Sahu","year":"2022","unstructured":"Sahu R, Mehan S, Kumar S, Prajapati A, Alshammari A, Alharbi M, Assiri MA, Narula AS (2022) Effect of alpha-mangostin in the prevention of behavioural and neurochemical defects in methylmercury-induced neurotoxicity in experimental rats. Toxicol Rep 9(April):977\u2013998. https:\/\/doi.org\/10.1016\/j.toxrep.2022.04.023","journal-title":"Toxicol Rep"},{"issue":"6","key":"5948_CR114","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1007\/s10571-015-0279-2","volume":"36","author":"NA Salem","year":"2016","unstructured":"Salem NA, Assaf N, Ismail MF, Khadrawy YA, Rat C-\u00c1P\u00c1 (2016) Ozone therapy in ethidium bromide-induced demyelination in rats: possible protective effect. Cell Mol Neurobiol 36(6):943\u2013954. https:\/\/doi.org\/10.1007\/s10571-015-0279-2","journal-title":"Cell Mol Neurobiol"},{"key":"5948_CR115","doi-asserted-by":"publisher","unstructured":"Sama RRK, Fallini C, Gatto R, Mckeon JE, Song Y, Rotunno MS, Penara S, Abdurakhmanov I, Landers JE, Brady ST, Bosco DA (2017)\u00a0ALS-linked FUS exerts a gain of toxic function involving aberrant p38 MAPK activation. 1\u201313. https:\/\/doi.org\/10.1038\/s41598-017-00091-1","DOI":"10.1038\/s41598-017-00091-1"},{"key":"5948_CR116","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jtemb.2018.09.004","volume":"51","author":"LNdaS Santana","year":"2019","unstructured":"Santana LNdaS, Bittencourt LO, Nascimento PC, Fernandes RM, Teixeira FB, Fernandes LMP, Freitas Silva MC, Nogueira LS, Amado LL, Crespo-Lopez ME, Maia CdoSF, Lima RR (2019) Low doses of methylmercury exposure during adulthood in rats display oxidative stress, neurodegeneration in the motor cortex and lead to impairment of motor skills. J Trace Elem Med Biol 51:19\u201327. https:\/\/doi.org\/10.1016\/j.jtemb.2018.09.004","journal-title":"J Trace Elem Med Biol"},{"issue":"August","key":"5948_CR117","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.neuro.2023.08.001","volume":"98","author":"P Sethi","year":"2023","unstructured":"Sethi P, Mehan S, Khan Z, Chhabra S (2023) Acetyl-11-keto-beta boswellic acid (AKBA) modulates CSTC-pathway by activating SIRT-1\/Nrf2-HO-1 signalling in experimental rat model of obsessive-compulsive disorder: evidenced by CSF, blood plasma and histopathological alterations. Neurotoxicology 98(August):61\u201385. https:\/\/doi.org\/10.1016\/j.neuro.2023.08.001","journal-title":"Neurotoxicology"},{"issue":"8","key":"5948_CR118","doi-asserted-by":"publisher","first-page":"3145","DOI":"10.1007\/s10072-021-05328-6","volume":"42","author":"A Shandilya","year":"2021","unstructured":"Shandilya A, Mehan S (2021) Dysregulation of IGF-1\/GLP-1 signaling in the progression of ALS: potential target activators and influences on neurological dysfunctions. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 42(8):3145\u20133166. https:\/\/doi.org\/10.1007\/s10072-021-05328-6","journal-title":"Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology"},{"issue":"12","key":"5948_CR119","doi-asserted-by":"publisher","first-page":"3878","DOI":"10.3390\/molecules27123878","volume":"27","author":"A Shandilya","year":"2022","unstructured":"Shandilya A, Mehan S, Kumar S, Sethi P, Narula AS, Alshammari A, Alharbi M, Alasmari AF (2022) Activation of IGF-1\/GLP-1 signalling via 4-hydroxyisoleucine prevents motor neuron impairments in experimental ALS-Rats exposed to methylmercury-induced neurotoxicity. Molecules (Basel) 27(12):3878. https:\/\/doi.org\/10.3390\/molecules27123878","journal-title":"Molecules (Basel)"},{"key":"5948_CR120","doi-asserted-by":"publisher","DOI":"10.1016\/j.mrrev.2024.108518","volume":"794","author":"R Sharma","year":"2024","unstructured":"Sharma R, Khan Z, Mehan S, Das G, Narula AS (2024a) Mutation Research-Reviews in Mutation Research Unraveling the multifaceted insights into amyotrophic lateral sclerosis\u202f: genetic underpinnings, pathogenesis, and therapeutic horizons. Mutat Res Rev Mutat Res 794:108518. https:\/\/doi.org\/10.1016\/j.mrrev.2024.108518","journal-title":"Mutat Res Rev Mutat Res"},{"key":"5948_CR121","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2024.105876","volume":"180","author":"R Sharma","year":"2024","unstructured":"Sharma R, Mehan S, Khan Z, Das G (2024b) Neurochemistry International Therapeutic potential of oleanolic acid in modulation of PI3K \/ Akt \/ mTOR \/ STAT-3 \/ GSK-3 \u03b2 signaling pathways and neuroprotection against methylmercury-induced neurodegeneration. Neurochem Int 180:105876. https:\/\/doi.org\/10.1016\/j.neuint.2024.105876","journal-title":"Neurochem Int"},{"issue":"1","key":"5948_CR122","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e24050","volume":"10","author":"S Sharma","year":"2024","unstructured":"Sharma S, Mehan S, Khan Z, Das G (2024c) Heliyon Icariin prevents methylmercury-induced experimental neurotoxicity\u202f: evidence from cerebrospinal fluid, blood plasma, brain samples, and in-silico investigations. Heliyon 10(1):e24050. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e24050","journal-title":"Heliyon"},{"key":"5948_CR123","doi-asserted-by":"publisher","unstructured":"Sharma S, Mehan S, Khan Z, Tiwari A, Kumar A, Gupta GD, Narula AS, Kalfin R (2024d) Exploring the neuroprotective potential of icariin through modulation of neural pathways in the treatment of neurological diseases. Curr Mol Med 24.\u00a0https:\/\/doi.org\/10.2174\/0115665240317650240924041923","DOI":"10.2174\/0115665240317650240924041923"},{"key":"5948_CR124","doi-asserted-by":"publisher","DOI":"10.2174\/0118761429326799241121104310","author":"K Sherawat","year":"2024","unstructured":"Sherawat K, Mehan S, Khan Z, Tiwari A, Gupta GD, Narula AS (2024) Neuroprotective potential of tanshinone-IIA in mitigating propionic acidinduced experimental autism-like behavioral and neurochemical alterations: insights into c-JNK and p38MAPK pathways. Curr Mol Pharmacol. https:\/\/doi.org\/10.2174\/0118761429326799241121104310","journal-title":"Curr Mol Pharmacol"},{"issue":"3","key":"5948_CR125","doi-asserted-by":"publisher","first-page":"100","DOI":"10.4103\/1947-2714.153921","volume":"7","author":"V Shinde","year":"2015","unstructured":"Shinde V, Yegnanarayan R, Shah P, Gupta A, Pophale P (2015) Antidepressant-like activity of flunarizine in modified tail suspension test in rats. N Am J Med Sci 7(3):100\u2013103. https:\/\/doi.org\/10.4103\/1947-2714.153921","journal-title":"N Am J Med Sci"},{"issue":"4","key":"5948_CR126","doi-asserted-by":"publisher","DOI":"10.1016\/j.phyplu.2021.100139","volume":"1","author":"A Singh","year":"2021","unstructured":"Singh A, Upadhayay S, Mehan S (2021a) Phytomedicine plus inhibition of c-JNK \/ p38MAPK signaling pathway by apigenin prevents neurobehavioral and neurochemical defects in ethidium bromide-induced experimental model of multiple sclerosis in rats\u202f: evidence from CSF, blood plasma and brain sam. Phytomedicine plus 1(4):100139. https:\/\/doi.org\/10.1016\/j.phyplu.2021.100139","journal-title":"Phytomedicine plus"},{"key":"5948_CR127","doi-asserted-by":"publisher","DOI":"10.1007\/s12640-021-00401-6","author":"A Singh","year":"2021","unstructured":"Singh A, Upadhayay S, Mehan S (2021b) Understanding abnormal c \u2011 JNK \/ p38MAPK signaling overactivation involved in the progression of multiple sclerosis\u202f: possible therapeutic targets and impact on neurodegenerative diseases. Neurotox Res. https:\/\/doi.org\/10.1007\/s12640-021-00401-6","journal-title":"Neurotox Res"},{"key":"5948_CR128","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuro.2026.103398","volume":"113","author":"G Singh","year":"2026","unstructured":"Singh G, Mehan S, Das G (2026) Neurotoxicology neuroprotection via IGF-1 neuronal signaling activation by melatonin and edaravone synergy in methylmercury-induced ALS-like neurotoxicity\u202f: comprehensive analysis of brain regions, spinal cord, CSF, and blood plasma. Neurotoxicology 113:103398. https:\/\/doi.org\/10.1016\/j.neuro.2026.103398","journal-title":"Neurotoxicology"},{"issue":"3","key":"5948_CR129","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1007\/s10072-024-07760-w","volume":"46","author":"R Soliman","year":"2025","unstructured":"Soliman R, Onbool E, Omran K, Fahmy N (2025) Clinical and epidemiological characteristics of amyotrophic lateral sclerosis in an Egyptian cohort. Neurol Sci 46(3):1225\u20131236. https:\/\/doi.org\/10.1007\/s10072-024-07760-w","journal-title":"Neurol Sci"},{"key":"5948_CR130","doi-asserted-by":"publisher","DOI":"10.3390\/antiox10060827","author":"M Soll","year":"2021","unstructured":"Soll M, Goldshtein H, Rotkopf R, Russek-Blum N, Gross Z (2021) A synthetic sod\/catalase mimic compound for the treatment of ALS. Antioxidants (Basel). https:\/\/doi.org\/10.3390\/antiox10060827","journal-title":"Antioxidants (Basel)"},{"key":"5948_CR131","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-025-05879-3","author":"C Staveri","year":"2025","unstructured":"Staveri C, Lykoura C, Melissaropoulos K, Liossis SNC (2025) Favorable outcomes for patients with refractory systemic lupus erythematosus treated with rituximab as evidenced with a follow-up of \u2265 10 years: a real-world evidence study. Rheumatol Int. https:\/\/doi.org\/10.1007\/s00296-025-05879-3","journal-title":"Rheumatol Int"},{"issue":"25","key":"5948_CR132","doi-asserted-by":"publisher","first-page":"5180","DOI":"10.1182\/blood-2009-06-228288","volume":"115","author":"R Stein","year":"2010","unstructured":"Stein R, Gupta P, Chen X, Cardillo TM, Furman RR, Chen S, Chang CH, Goldenberg DM (2010) Therapy of B-cell malignancies by anti-HLA-DR humanized monoclonal antibody, IMMU-114, is mediated through hyperactivation of ERK and JNK MAP kinase signaling pathways. Blood 115(25):5180\u20135190. https:\/\/doi.org\/10.1182\/blood-2009-06-228288","journal-title":"Blood"},{"issue":"1","key":"5948_CR133","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.taap.2007.10.010","volume":"227","author":"J Stringari","year":"2008","unstructured":"Stringari J, Nunes AKC, Franco JL, Bohrer D, Garcia SC, Dafre AL, Milatovic D, Souza DO, Rocha JBT, Aschner M, Farina M (2008) Prenatal methylmercury exposure hampers glutathione antioxidant system ontogenesis and causes long-lasting oxidative stress in the mouse brain. Toxicol Appl Pharmacol 227(1):147\u2013154. https:\/\/doi.org\/10.1016\/j.taap.2007.10.010","journal-title":"Toxicol Appl Pharmacol"},{"key":"5948_CR134","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1742-2094-8-19","volume":"8","author":"S Tada","year":"2011","unstructured":"Tada S, Okuno T, Yasui T, Nakatsuji Y, Sugimoto T, Kikutani H, Sakoda S (2011) Deleterious effects of lymphocytes at the early stage of neurodegeneration in an animal model of amyotrophic lateral sclerosis. J Neuroinflammation 8:1\u201310. https:\/\/doi.org\/10.1186\/1742-2094-8-19","journal-title":"J Neuroinflammation"},{"key":"5948_CR135","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-53826-w","author":"C Tang","year":"2024","unstructured":"Tang C, Wang Z, Xie Y, Fei Y, Luo J, Wang C, Ying Y, He P, Yan R, Chen Y, Huang J, Xu Y, Wang Z, Heng BC, Liu H, Li J, Yin Z, Wu H, Chen W, Ouyang H, Chen X, Shen W (2024) Classification of distinct tendinopathy subtypes for precision therapeutics. Nat Commun. https:\/\/doi.org\/10.1038\/s41467-024-53826-w","journal-title":"Nat Commun"},{"issue":"May","key":"5948_CR136","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbih.2024.100864","volume":"41","author":"P Thunberg","year":"2024","unstructured":"Thunberg P, Fresnais D, Hamilton P, Bejerot S, Humble MB (2024) Immunomodulatory treatment may change functional and structural brain imaging in severe mental disorders. Brain Behav Immun Health 41(May):100864. https:\/\/doi.org\/10.1016\/j.bbih.2024.100864","journal-title":"Brain Behav Immun Health"},{"issue":"9","key":"5948_CR137","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.2174\/1389450121666201020155010","volume":"22","author":"A Tiwari","year":"2020","unstructured":"Tiwari A, Rahi S, Mehan S (2020) Elucidation of abnormal extracellular regulated kinase (ERK) signaling and associations with syndromic and non-syndromic autism. Curr Drug Targets 22(9):1071\u20131086. https:\/\/doi.org\/10.2174\/1389450121666201020155010","journal-title":"Curr Drug Targets"},{"issue":"3","key":"5948_CR138","doi-asserted-by":"publisher","first-page":"288","DOI":"10.3390\/brainsci11030288","volume":"11","author":"A Tiwari","year":"2021","unstructured":"Tiwari A, Khera R, Rahi S, Mehan S, Makeen HA, Khormi YH, Rehman MU, Khan A (2021) Neuroprotective effect of \u03b1-mangostin in the ameliorating propionic acid-induced experimental model of autism in wistar rats. Brain Sci 11(3):288. https:\/\/doi.org\/10.3390\/brainsci11030288","journal-title":"Brain Sci"},{"issue":"May","key":"5948_CR139","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnmol.2018.00165","volume":"11","author":"H Tong","year":"2018","unstructured":"Tong H, Zhang X, Meng X, Lu L, Mai D, Qu S (2018) Simvastatin inhibits activation of NADPH oxidase\/p38 MAPK pathway and enhances expression of antioxidant protein in Parkinson disease models. Front Mol Neurosci 11(May):1\u201316. https:\/\/doi.org\/10.3389\/fnmol.2018.00165","journal-title":"Front Mol Neurosci"},{"issue":"8","key":"5948_CR140","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.3390\/genes13081324","volume":"13","author":"S Upadhayay","year":"2022","unstructured":"Upadhayay S, Mehan S, Prajapati A, Sethi P, Suri M, Zawawi A, Almashjary MN, Tabrez S (2022) Nrf2\/HO-1 signaling stimulation through Acetyl-11-Keto-Beta-Boswellic Acid (AKBA) provides neuroprotection in ethidium bromide-induced experimental model of multiple sclerosis. Genes 13(8):1324. https:\/\/doi.org\/10.3390\/genes13081324","journal-title":"Genes"},{"issue":"1","key":"5948_CR141","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1007\/s12011-018-1351-9","volume":"187","author":"N Uysal","year":"2019","unstructured":"Uysal N, Kizildag S, Yuce Z, Guvendi G, Kandis S, Koc B, Karakilic A, Camsari UM, Ates M (2019) Timeline (bioavailability) of magnesium compounds in hours: which magnesium compound works best? Biol Trace Elem Res 187(1):128\u2013136. https:\/\/doi.org\/10.1007\/s12011-018-1351-9","journal-title":"Biol Trace Elem Res"},{"key":"5948_CR142","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2019.e01541","author":"SS Valvassori","year":"2019","unstructured":"Valvassori SS, Gava FF, Dal-Pont GC, Sim\u00f5es HL, Damiani-Neves M, Andersen ML, Boeck CR, Quevedo J (2019) Effects of lithium and valproate on ERK\/JNK signaling pathway in an animal model of mania induced by amphetamine. Heliyon. https:\/\/doi.org\/10.1016\/j.heliyon.2019.e01541","journal-title":"Heliyon"},{"issue":"10","key":"5948_CR143","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1007\/s00415-019-09427-5","volume":"266","author":"RPA Van Eijk","year":"2019","unstructured":"Van Eijk RPA, Bakers JNE, Bunte TM, De Fockert AJ, Eijkemans MJC (2019) Accelerometry for remote monitoring of physical activity in amyotrophic lateral sclerosis\u202f: a longitudinal cohort study. J Neurol 266(10):2387\u20132395. https:\/\/doi.org\/10.1007\/s00415-019-09427-5","journal-title":"J Neurol"},{"issue":"2016","key":"5948_CR144","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.jtemb.2016.12.012","volume":"43","author":"M Vinceti","year":"2017","unstructured":"Vinceti M, Filippini T, Mandrioli J, Violi F, Bargellini A, Weuve J, Fini N, Grill P, Michalke B (2017) Lead, cadmium and mercury in cerebrospinal fluid and risk of amyotrophic lateral sclerosis: a case-control study. J Trace Elem Med Biol 43(2016):121\u2013125. https:\/\/doi.org\/10.1016\/j.jtemb.2016.12.012","journal-title":"J Trace Elem Med Biol"},{"key":"5948_CR145","doi-asserted-by":"publisher","unstructured":"Vinceti M, Filippini T, Mandrioli J, Violi F, Weuve J, Fini N, Grill P, Michalke B, Hospital SA, Biogeochemistry A (2018)\u00a0HHS public access. 121\u2013125. https:\/\/doi.org\/10.1016\/j.jtemb.2016.12.012.Lead","DOI":"10.1016\/j.jtemb.2016.12.012.Lead"},{"key":"5948_CR146","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.neuroscience.2018.03.008","volume":"379","author":"TH Wang","year":"2018","unstructured":"Wang TH, Wang SY, Wang XD, Jiang HQ, Yang YQ, Wang Y, Cheng JL, Zhang CT, Liang WW, Feng HL (2018a) N EUROSCIENCE Fisetin exerts antioxidant and neuroprotective effects in multiple mutant hSOD1 models of amyotrophic lateral sclerosis by activating ERK. Neuroscience 379:152\u2013166. https:\/\/doi.org\/10.1016\/j.neuroscience.2018.03.008","journal-title":"Neuroscience"},{"issue":"January","key":"5948_CR147","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.brainresbull.2018.02.015","volume":"139","author":"W Wang","year":"2018","unstructured":"Wang W, Wen D, Duan W, Yin J, Cui C, Wang Y, Li Z (2018b) Systemic administration of scAAV9-IGF1 extends survival in SOD1 G93A ALS mice via inhibiting p38 MAPK and the JNK-mediated apoptosis pathway. Brain Res Bull 139(January):203\u2013210. https:\/\/doi.org\/10.1016\/j.brainresbull.2018.02.015","journal-title":"Brain Res Bull"},{"issue":"5","key":"5948_CR148","doi-asserted-by":"publisher","first-page":"417","DOI":"10.2174\/1871527320666210126113848","volume":"20","author":"RK Yadav","year":"2021","unstructured":"Yadav RK, Minz E, Mehan S (2021) Understanding abnormal c-JNK\/p38MAPK signaling in amyotrophic lateral sclerosis: potential drug targets and influences on neurological disorders. CNS Neurol Disord Drug Targets 20(5):417\u2013429. https:\/\/doi.org\/10.2174\/1871527320666210126113848","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"5948_CR149","doi-asserted-by":"publisher","unstructured":"Yadav RK, Mehan S, Sahu R, Kumar S, Khan A, Bratty MAl (2022)\u00a0Protective effects of apigenin on neurochemical abnormalities and neurotoxicity in rats. 41, 1\u201320. https:\/\/doi.org\/10.1177\/09603271221084276","DOI":"10.1177\/09603271221084276"},{"issue":"9","key":"5948_CR150","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1038\/s41401-020-00558-4","volume":"42","author":"X Yang","year":"2021","unstructured":"Yang X, Chu S, Wang Z, Li F, Yuan Y, Chen N (2021) Ginsenoside Rg1 exerts neuroprotective effects in 3-nitropronpionic acid-induced mouse model of Huntington\u2019s disease via suppressing MAPKs and NF-\u03baB pathways in the striatum. Acta Pharmacol Sin 42(9):1409\u20131421. https:\/\/doi.org\/10.1038\/s41401-020-00558-4","journal-title":"Acta Pharmacol Sin"},{"key":"5948_CR151","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2023.1289467","author":"J Yang","year":"2023","unstructured":"Yang J, Liu T, Zhang L, Li X, Du FP, Liu Q, Dong H, Liu Y (2023) Eosinophils at diagnosis are elevated in amyotrophic lateral sclerosis. Front Neurol. https:\/\/doi.org\/10.3389\/fneur.2023.1289467","journal-title":"Front Neurol"},{"key":"5948_CR152","doi-asserted-by":"publisher","first-page":"1","DOI":"10.34133\/cbsystems.0262","volume":"6","author":"L Yang","year":"2025","unstructured":"Yang L, Gao Y, Lopes LS, Lian J, Fu W, Tan H, Yang S, Xie Z, Huang Y, Zhang J, Lu Y, Tang H, Xiong B, Wei X, Xie L, Peng Y, Liu X, Han H (2025) Accelerated molecular transportation in the brain extracellular space with 755-nm light attenuates post-stroke cognitive impairment in rats. Cyborg and Bionic Systems 6:1\u201321. https:\/\/doi.org\/10.34133\/cbsystems.0262","journal-title":"Cyborg and Bionic Systems"},{"issue":"2","key":"5948_CR153","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1248\/jhs.51.220","volume":"51","author":"A Yasutake","year":"2005","unstructured":"Yasutake A, Nagano M, Nakano A (2005) Simple method for methylmercury estimation in biological samples using atomic absorption spectroscopy. J Health Sci 51(2):220\u2013223. https:\/\/doi.org\/10.1248\/jhs.51.220","journal-title":"J Health Sci"},{"key":"5948_CR154","doi-asserted-by":"publisher","unstructured":"Yin (2009)\u00a0NIH public access. 107(4):1083\u20131090. https:\/\/doi.org\/10.1111\/j.1471-4159.2008.05683.x.The","DOI":"10.1111\/j.1471-4159.2008.05683.x.The"},{"key":"5948_CR155","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.neuro.2023.12.002","volume":"100","author":"Y Yuan","year":"2024","unstructured":"Yuan Y, Bailey JM, Rivera-Lopez GM, Atchison WD (2024) Preferential potentiation of AMPA-mediated currents in brainstem hypoglossal motoneurons by subchronic exposure of mice expressing the human superoxide dismutase 1 G93A gene mutation to neurotoxicant methylmercury in vivo. Neurotoxicology 100:72\u201384. https:\/\/doi.org\/10.1016\/j.neuro.2023.12.002","journal-title":"Neurotoxicology"},{"issue":"1","key":"5948_CR156","doi-asserted-by":"publisher","first-page":"9631","DOI":"10.1038\/s41467-025-64622-5","volume":"16","author":"Y Zhao","year":"2025","unstructured":"Zhao Y, Savelieff MG, Li X, Guo K, Wang K, Li M, Li B, Iyer G, Sakowski SA, Zhao L, Teener SJ, Bakulski KM, Dou JF, Traynor BJ, Karnovsky A, Batterman SA, Hur J, Goutman SA, Sartor MA, Feldman EL (2025) Gene expression signatures from whole blood predict amyotrophic lateral sclerosis case status and survival. Nat Commun 16(1):9631. https:\/\/doi.org\/10.1038\/s41467-025-64622-5","journal-title":"Nat Commun"},{"issue":"6","key":"5948_CR157","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1002\/mus.27233","volume":"63","author":"Y Zhou","year":"2021","unstructured":"Zhou Y, Yan C, Gu X, Zhou L, Lu J, Zhu W, Huan X, Luo S, Zhong H, Lin J, Lu J, Zhao C, Xi J (2021) Short-term effect of low-dose rituximab on myasthenia gravis with muscle-specific tyrosine kinase antibody. Muscle Nerve 63(6):824\u2013830. https:\/\/doi.org\/10.1002\/mus.27233","journal-title":"Muscle Nerve"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05948-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05948-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05948-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T15:07:05Z","timestamp":1791904025000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-026-05948-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,13]]},"references-count":157,"alternative-id":["5948"],"URL":"https:\/\/doi.org\/10.1007\/s00210-026-05948-9","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,13]]},"assertion":[{"value":"10 August 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was carried out in accordance with the Institutional Animal Ethics Committee (IAEC) norms, with registration number 816\/PO\/ReBiBt\/S\/04\/CPCSEA 06\/08\/2004 as ISFCP\/IAEC\/CCSEA\/Meeting No: 08\/2025\/Protocol No. 97. approved by the RAB Committee, ISFCP, Moga, Punjab, India.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors approve of submitting the publication.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}